Previous studies have failed to clearly and consensually show that Galectin-3 was a predictor of ventricular remodeling after MI [20], and in the present study, the plasma level of Galectin-3 was not directly predictive of this remodeling—i.e. The gene discussed is LGALS3; the disease is myocardial infarction.